On 27 April 2021, Dr John Liddicoat (LML Senior Research Associate) participated in ‘Drug Repurposing in the EU – an Innovation Failure’. At this event, part of the Finnish IPR University Center’s Dialogue of Experts series, Dr Liddicoat elaborated on the findings of two forthcoming papers: ‘Has the EU Incentive for Drug Repositioning been Effective? An Empirical Analysis’ (forthcoming in International Review of Intellectual Property and Competition Law), and ‘Do Generics Stop Repositioning’ (a work in progress investigating whether clinical trials strop for drugs when a generic enters the market).
Further information can be found here.